FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

ICH Guide Seeks to Reduce Rat Studies

The International Council for Harmonization releases its Addendum to the Guideline on Testing for Carcinogenicity of Pharmaceuticals S1B(R1) with the ...

Federal Register

Environmental Impact Statement for Certain Sunscreens

Federal Register notice: FDA announces its intent to prepare an environmental impact statement to evaluate the potential environmental effects of revi...

Human Drugs

5 GDUFA 3 Reauthorization Meeting Summaries

FDA releases summaries highlighting topics discussed at five GDUFA 3 reauthorization meetings.

Medical Devices

HHS Should Reverse LDT Policy: House Committee

The House Energy and Commerce Committee asks HHS to reverse the Trump administration's decision to remove FDA authority to require premarket review of...

Biologics

Hearing on BioSolutions Covid Vaccine Troubles

The House Select Subcommittee on the Coronavirus Crisis announces a hearing that will take testimony next week from two Emergent BioSolutions top exec...

Human Drugs

New FDA Head Should Push Trial Transparency: Op-Ed

Two law students and a professor say whoever becomes FDA commissioner should commit to enforcing clinical trial transparency.

Medical Devices

FDA Alert on Pacemaker Interference Caused by Cell Phone

FDA advises pacemaker and other electronic implant device wearers to keep their cell phones, smart watches and other electronic devices at least six i...

Human Drugs

After 2 Rejections, Heron Pain NDA Finally Approved

FDA approves a Heron Therapeutics NDA for Zynrelef (bupivacaine and meloxicam) extended-release solution for use in adults for soft tissue or periarti...

Medical Devices

Abbott Recall of 2 Pacemaker Models is Class 1

FDA says an Abbott recall of some Endurity and Assurity bradycardia pacemakers is Class 1.

Human Drugs

FDA May Be Too Reliant on User Fees: Professor

University of Connecticut pharmacy professor C. Michael White says FDA may be too dependent on user fees and needs more taxpayer funding for programs ...